Logo Image

Podcasts

Recent Episodes

Navigating Personality Disorders in Cancer Care
Navigating Personality Disorders in Cancer Care
Experts discuss how updated findings from the TALAPRO-3 and PROTEUS trials may impact the prostate cancer paradigm.
ASCO 2026: Translating the Top Prostate Cancer Data Into Clinical Action
Experts discuss abstracts from the 2026 ASCO Annual Meeting that may represent critical advances across multiple myeloma, leukemia, and lymphoma.
Unraveling Key Hematologic Oncology Developments at ASCO 2026
Nathan Goodyear, MD, discussed how prescribing exercise may enhance the efficacy of standard oncologic regimens for patients with cancer.
Integrating Exercise and Lifestyle Intervention Into Oncologic Therapy
How the Landscape of GI Oncology is Evolving: A 2026 ASCO Preview
How the Landscape of GI Oncology is Evolving: A 2026 ASCO Preview
Host Brandon Mancini, MD, MBA, FACRO, discusses stereotactic radiosurgery, proton therapy, and other relevant modalities in the management of brain tumors.
Why Do CNS Malignancies Matter in Radiation Oncology?
Mitchell E. Horwitz, MD, discussed how omidubicel and other advances in allogeneic transplantation have impacted different hematologic oncology populations.
Navigating the Dynamic Landscape of Stem Cell Transplantation
Combining zedoresertib with lunresertib yielded activity in patients with CCNE1-altered platinum-resistant ovarian cancer in the phase 1 MYTHIC trial.
Are Zedoresertib and Lunresertib an Efficacious Combo Across Solid Tumors?
Experts discuss how checkpoint inhibitors, cystectomy, and other treatment modalities fit into the current landscape for non–muscle-invasive bladder cancer.
Optimizing Therapeutic Strategies Across the NMIBC Paradigm
Experts highlight advances in cellular therapies that were discussed at the 2026 National ICE-T Conference in Charlotte, North Carolina.
What Does the Future Hold for Immune Effector Cell Therapies?

All series

Recent Episodes

Recent Episodes

Oncology On the Go With ASTCT Talks

Oncology On the Go With ASTCT Talks

ONCOLOGY Decoded

ONCOLOGY Decoded

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

FDA Approval Alert: The Need-to-Know

FDA Approval Alert: The Need-to-Know

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO